Current Survival Rates For Leukemia
The four main types of leukemia are: There is no standard staging system for leukemia. Therapy with interferon-alpha is another treatment option, especially for patients with intercurrent infection. An unfavorable prognosis can change, too. J Clin Oncol 21 (5 891-6, 2003. (2002) Cancer Statistics, 2002.
Hegenbart U, Niederwieser D, Sandmaier BM, Maris MB, Shizuru JA, Greinix H,.
Larson RA, Boogaerts M, gear Estey E, Karanes C, Stadtmauer EA, Sievers EL,. Los Angeles, CA: Practice Management Information Corporation; 2005. Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission. De Jonge HJ, de Bont ES, Valk PJ, Schuringa JJ, Kies M, Woolthuis CM,. Researchers found that the five-year survival rate for adolescents and young adults was 80 percent, compared with younger children who enjoyed.4 percent rate of survival.
Leukaemia (all subtypes combined) survival statistics
A critical appraisal of lowdose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplasticsyndromes.
Kantarjian H, Ravandi F, O'Brien S, Cortes J, Faderl S, Garcia-Manero G,.
Survival statistics for acute lymphoblastic leukaemia (ALL) Cancer
2009; 113(1 28-36 PMC free article PubMed. Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival. 1997;89(12 4531-6 PubMed.
2006;106(5 1090-8 PubMed.
Suggested styles are: Web content: Cancer Research UK, full URL of the page, Accessed month year.
When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley. Prospective feasibility analysis of reducedintensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (hsct) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). 2007;17 (8 584-90 PubMed. 2001;98(5 1302-11 PubMed.
Leukemia - Acute Myeloid - AML: Statistics
Leukemia - Chronic Lymphocytic - CLL: Statistics
Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia. 2010;116(6 886-92 PMC free article PubMed. Various distinctive cytogenetic abnormalities in patients with acute myeloid leukaemia aged 60 years and older express adverse prognostic value: results from a prospective clinical trial. Juliusson G, Antunovic P, Derolf A, Lehmann S, Mollgard L, Stockelberg D,. 2002;40(8 Suppl IV-3-18 PubMed. Deyo RA, Cherkin DC, Ciol.
Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison CJ,. Atlanta, Ga: American Cancer Society. He also noted that not only do these older patients tend to have a disease that is more resistant to chemotherapy, but they also experience more toxic side effects from the treatment they receive.